Hydrotalcite-Embedded Magnetite Nanoparticles for Hyperthermia-Triggered Chemotherapy
Authors:
- Konstantinos SimeonidisKonstantinos Simeonidis
- Efthimia KapraraEKEfthimia Kaprara
- Pilar Rivera-GilPilar Rivera-Gil
- Ruixue XuRXRuixue Xu
- Francisco J. TeranFTFrancisco J. Teran
- Evgenios KokkinosEKEvgenios Kokkinos
- Athanassios MitropoulosAthanassios Mitropoulos
- Nikolaos ManiotisNikolaos Maniotis
- Lluis BalcellsLBLluis Balcells
Open Access
- 9 July 2021
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 11 (7) , 1796
Abstract
A magnetic nanocomposite, consisting of Fe3O4 nanoparticles embedded into a Mg/Al layered double hydroxide (LDH) matrix, was developed for cancer multimodal therapy, based on the combination of local magnetic hyperthermia and thermally induced drug delivery. The synthesis procedure involves the sequential hydrolysis of iron salts (Fe2+, Fe3+) and Mg2+/Al3+ nitrates in a carbonate-rich mild alkaline environment followed by the loading of 5-fluorouracil, an anionic anticancer drug, in the interlayer LDH space. Magnetite nanoparticles with a diameter around 30 nm, dispersed in water, constitute the hyperthermia-active phase able to generate a specific loss of power of around 500 W/g-Fe in an alternating current (AC) magnetic field of 24 kA/m and 300 kHz as determined by AC magnetometry and calorimetric measurements. Heat transfer was found to trigger a very rapid release of drug which reached 80% of the loaded mass within 10 min exposure to the applied field. The potential of the Fe3O4/LDH nanocomposites as cancer treatment agents with minimum side-effects, owing to the exclusive presence of inorganic phases, was validated by cell internalization and toxicity assays.Keywords
Funding Information
- Stavros Niarchos Foundation (Eastern Macedonia and Thrace Institute of Technology fellowships)
- European Commission (654360)
- Ministerio de Ciencia e Innovación (MAT2017-85617-R, SEV-2016-0686, RED2018-102626-T)
- Comunidad de Madrid (NANOMAGCOST)
- COST Actions (CA17115 (MyWave), CA17140 (Nano2Clinic))
- Ministerio de Ciencia, Innovación y Universidades (RYC-2012-10059, MDM-2014-0370-04, CTQ2013-45433-PFEDER, MAT2016-75362-C3-2-R, AEI-SAF2015-73052-EXP, 2017 SGR 1054)
This publication has 49 references indexed in Scilit:
- Multiple Internalization Pathways of Polyelectrolyte Multilayer Capsules into Mammalian CellsACS Nano, 2013
- Quantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite chargeJournal of Nanobiotechnology, 2012
- Exchange-coupled magnetic nanoparticles for efficient heat inductionNature Nanotechnology, 2011
- Nearly monodispersed core–shell structural Fe3O4@DFUR–LDH submicro particles for magnetically controlled drug delivery and releaseChemical Communications, 2010
- Magnetic, Luminescent Eu‐Doped Mg–Al Layered Double Hydroxide and Its Intercalation for IbuprofenChemistry – A European Journal, 2010
- Bioinorganic Magnetic Core−Shell Nanocomposites Carrying Antiarthritic Agents: Intercalation of Ibuprofen and Glucuronic Acid into Mg−Al−Layered Double Hydroxides Supported on Magnesium FerriteInorganic Chemistry, 2009
- Synthesis, Characterization, and Magnetically Controlled Release Behavior of Novel Core−Shell Structural Magnetic Ibuprofen-Intercalated LDH NanohybridsThe Journal of Physical Chemistry C, 2009
- A novel core-shell structured magnetic organic-inorganic nanohybrid involving drug-intercalated layered double hydroxides coated on a magnesium ferrite core for magnetically controlled drug releaseJournal of Materials Chemistry, 2009
- Uniform and water stable magnetite nanoparticles with diameters around the monodomain–multidomain limitJournal of Physics D: Applied Physics, 2008
- Applications of carbon nanotubes in drug deliveryCurrent Opinion in Chemical Biology, 2005